MX2019003298A - Proteinas de union recombinantes y sus usos. - Google Patents

Proteinas de union recombinantes y sus usos.

Info

Publication number
MX2019003298A
MX2019003298A MX2019003298A MX2019003298A MX2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A
Authority
MX
Mexico
Prior art keywords
binding proteins
recombinant binding
nucleic acids
recombinant
pharmaceutical compositions
Prior art date
Application number
MX2019003298A
Other languages
English (en)
Inventor
Fiedler Ulrike
DOLADO Ignacio
Metz Clara
Maria STROBEL Heike
Original Assignee
Molecular Partners Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Partners Ag filed Critical Molecular Partners Ag
Publication of MX2019003298A publication Critical patent/MX2019003298A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se desvelan nuevas proteínas de unión recombinantes, que comprenden dominios diseñados con repeticiones de anquirina con especificidad de unión para el HER2, y que comprenden dominios diseñados con repeticiones de anquirina con especificidad de unión para la seroalbúmina, así como los ácidos nucleicos que codifican dichas proteínas de unión recombinantes, composiciones farmacéuticas que comprenden dichas proteínas de unión recombinantes o ácidos nucleicos y el uso de dichas proteínas de unión recombinantes, ácidos nucleicos o composiciones farmacéuticas en el tratamiento de enfermedades.
MX2019003298A 2016-09-22 2017-09-20 Proteinas de union recombinantes y sus usos. MX2019003298A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (1)

Publication Number Publication Date
MX2019003298A true MX2019003298A (es) 2019-09-26

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003298A MX2019003298A (es) 2016-09-22 2017-09-20 Proteinas de union recombinantes y sus usos.

Country Status (20)

Country Link
US (2) US10717772B2 (es)
EP (1) EP3515933B9 (es)
JP (1) JP6976335B2 (es)
KR (1) KR102270315B1 (es)
CN (1) CN109790206A (es)
AR (1) AR109680A1 (es)
AU (1) AU2017331329B2 (es)
BR (1) BR112019005587A2 (es)
CA (1) CA3036301C (es)
CL (1) CL2019000729A1 (es)
CO (1) CO2019002609A2 (es)
ES (1) ES2953516T3 (es)
IL (1) IL265489B (es)
MX (1) MX2019003298A (es)
MY (1) MY196882A (es)
NZ (1) NZ751689A (es)
PH (1) PH12019500596A1 (es)
SA (1) SA519401369B1 (es)
WO (1) WO2018054971A1 (es)
ZA (1) ZA201901592B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021024231A2 (pt) * 2019-06-04 2022-04-26 Molecular Partners Ag Proteínas de ligação fap recombinantes e uso da mesma
CA3139051A1 (en) * 2019-06-04 2020-12-10 Christian REICHEN Multispecific proteins
WO2020245171A1 (en) 2019-06-04 2020-12-10 Molecular Partners Ag Designed ankyrin repeat domain with improved stability
AU2020399230A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Recombinant peptide-MHC complex binding proteins and their generation and use
CR20220618A (es) 2020-05-06 2023-01-19 Molecular Partners Ag Nuevas proteinas de unión a repeticiones de anquirina y sus usos
AU2021271131A1 (en) * 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use
BR112022023049A2 (pt) 2020-05-14 2022-12-20 Molecular Partners Ag Proteínas multiespecíficas
AU2021403833A1 (en) 2020-12-16 2023-07-27 Molecular Partners Ag Novel slow-release prodrugs
AU2022233791A1 (en) 2021-03-09 2023-09-28 Molecular Partners Ag Novel darpin based cd123 engagers
WO2022190008A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Protease cleavable prodrugs
AU2022231913A1 (en) 2021-03-09 2023-09-28 Molecular Partners Ag Novel darpin based cd33 engagers
MX2023010543A (es) 2021-03-09 2023-10-13 Molecular Partners Ag Ligadores multiespecificos de celulas t novedosos basados en darpin.
WO2023110983A1 (en) 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
WO2024028278A1 (en) 2022-08-01 2024-02-08 Molecular Partners Ag Charge modified designed repeat domains and their use
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
WO2002020565A2 (en) 2000-09-08 2002-03-14 Universität Zürich Collections of repeat proteins comprising repeat modules
AU2002331720B2 (en) * 2001-08-24 2007-10-11 Johns Hopkins University Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
EA013615B1 (ru) 2004-11-12 2010-06-30 Байер Шеринг Фарма Акциенгезельшафт Рекомбинантный онколитический парамиксовирус и его применение
NZ564695A (en) 2005-07-08 2009-02-28 Univ Zuerich Phage display using cotranslational translocation of fusion polypeptides
JP2010539915A (ja) 2007-09-24 2010-12-24 ユニバーシティ・オブ・チューリッヒ 設計されたアルマジロリピートタンパク質
AU2008328781A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
JP5954990B2 (ja) 2008-11-03 2016-07-20 モレキュラー・パートナーズ・アーゲーMolecular Partners Ag Vegf−aレセプター相互作用を阻害する結合タンパク質
AR081361A1 (es) 2010-04-30 2012-08-29 Molecular Partners Ag Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
CA2818990C (en) 2010-11-26 2021-06-15 Molecular Partners Ag Designed repeat proteins binding to serum albumin
EP2702069A4 (en) 2011-04-29 2015-04-29 Janssen Biotech Inc IL4 / IL13 BINDING REPEAT PROTEINS AND USES THEREOF
BR112014032316A2 (pt) 2012-06-28 2017-06-27 Molecular Partners Ag proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
US10093740B2 (en) * 2012-10-15 2018-10-09 Universitat Zurich Bispecific HER2 ligands for cancer therapy
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
WO2014191574A1 (en) 2013-05-31 2014-12-04 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
ES2953482T3 (es) 2015-04-02 2023-11-13 Molecular Partners Ag Dominios de repetición de anquirina diseñados con especificidad de unión para la albúmina sérica

Also Published As

Publication number Publication date
US10717772B2 (en) 2020-07-21
CA3036301C (en) 2021-04-20
RU2019111628A3 (es) 2020-10-30
CL2019000729A1 (es) 2019-06-14
IL265489B (en) 2021-07-29
AR109680A1 (es) 2019-01-09
US20180155402A1 (en) 2018-06-07
MY196882A (en) 2023-05-08
BR112019005587A2 (pt) 2019-06-11
KR102270315B1 (ko) 2021-06-29
EP3515933B1 (en) 2023-06-07
AU2017331329A1 (en) 2019-04-04
IL265489A (en) 2019-05-30
KR20190050802A (ko) 2019-05-13
NZ751689A (en) 2021-07-30
CA3036301A1 (en) 2018-03-29
ES2953516T3 (es) 2023-11-14
EP3515933C0 (en) 2023-06-07
ZA201901592B (en) 2021-04-28
JP2019531093A (ja) 2019-10-31
SA519401369B1 (ar) 2022-12-22
CN109790206A (zh) 2019-05-21
WO2018054971A1 (en) 2018-03-29
EP3515933A1 (en) 2019-07-31
US20210130420A1 (en) 2021-05-06
RU2019111628A (ru) 2020-10-19
JP6976335B2 (ja) 2021-12-08
EP3515933B9 (en) 2023-08-16
PH12019500596A1 (en) 2019-07-29
AU2017331329B2 (en) 2020-10-29
CO2019002609A2 (es) 2019-05-31

Similar Documents

Publication Publication Date Title
PH12019500596A1 (en) Recombinant binding proteins and their use
SA517390092B1 (ar) مجالات تكرار أنكيرين مصمَّمة ذات نوعية ربط تجاه ألبومين مصل
PH12018502361A1 (en) Gdf15 fusion proteins and uses thereof
MX2017014908A (es) Proteinas de union triespecificas y metodos de uso.
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
GEP20227447B (en) Constructs having sirp-alpha domain or variant thereof
WO2015109124A3 (en) Immunomodulatory agents
PH12020551907A1 (en) Antagonizing cd73 antibody
MX2022007122A (es) Dominios de repetición de anquirina diseñados con residuos de superficie alterados.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
EA201792466A1 (ru) АНТИТЕЛА ПРОТИВ FcRn
WO2019014360A8 (en) POLYPEPTIDES BINDING COMPONENT C5 OR SERUM ALBUMIN COMPONENT AND FUSION PROTEINS THEREOF
MX2021012047A (es) Polipeptidos de fusion de serpina y metodos para utilizar los mismos.
MX2015000754A (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
MX2019014504A (es) Inmunoglobulinas de union a agrecano.
MX2021014649A (es) Dominio de repetición de anquirina diseñado con estabilidad mejorada.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
MX2020001287A (es) Receptor de linfocitos t (tcrs) especificos de braf y usos de los mismos.
MX2019014448A (es) Inmunoglobulinas de enlace a mmp13.
PH12019502449A1 (en) Anti-jagged1 antigen binding proteins
MX2020009507A (es) Anticuerpos de dominio individual que se unen a la neurotoxina del tetanos.
WO2016040767A3 (en) Chrdl-1 epitopes and antibodies

Legal Events

Date Code Title Description
FG Grant or registration